Literature DB >> 10980951

Endoscopic ablation of Barrett's esophagus.

M B Fennerty1.   

Abstract

Barrett's esophagus is a premalignant lesion of the esophagus that arises as an abnormal tissue response to epithelial injury from gastroesophageal reflux. Barrett's esophagus has previously been considered an irreversible lesion that required life-long surveillance to prevent malignant transformation. Recently, combination therapy with pharmacologic or surgical control of acid reflux combined with endoscopic delivery of a mucosal injury appears to have the capability of reversing superficial Barrett's tissue, and perhaps deeper tissue as well. Whether Barrett's esophagus is cured and cancer/dysplasia prevented by these techniques will require long-term follow-up of these patients.

Entities:  

Mesh:

Year:  1999        PMID: 10980951     DOI: 10.1007/s11894-999-0036-0

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  30 in total

1.  Barrett's esophagus: what do we really know about this disease?

Authors:  M B Fennerty
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

Review 2.  Barrett's esophagus.

Authors:  S J Spechler; R K Goyal
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

3.  Photodynamic therapy: a new light on Barrett's esophagus.

Authors:  C J Lightdale
Journal:  Gastrointest Endosc       Date:  1995-07       Impact factor: 9.427

4.  Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus.

Authors:  M A Laukka; K K Wang
Journal:  Gastrointest Endosc       Date:  1995-07       Impact factor: 9.427

5.  Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus.

Authors:  B Overholt; M Panjehpour; E Tefftellar; M Rose
Journal:  Gastrointest Endosc       Date:  1993 Jan-Feb       Impact factor: 9.427

6.  A centering balloon for photodynamic therapy of esophageal cancer tested in a canine model.

Authors:  B F Overholt; R C DeNovo; M Panjehpour; M G Petersen
Journal:  Gastrointest Endosc       Date:  1993 Nov-Dec       Impact factor: 9.427

7.  Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease.

Authors:  C Winters; T J Spurling; S J Chobanian; D J Curtis; R L Esposito; J F Hacker; D A Johnson; D F Cruess; J D Cotelingam; M S Gurney
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

8.  Failure of Nd-YAG photocoagulation therapy as treatment for Barrett's oesophagus--a pilot study.

Authors:  W Luman; A M Lessels; K R Palmer
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 2.566

Review 9.  Photodynamic therapy and cancer of the esophagus.

Authors:  N E Marcon
Journal:  Semin Oncol       Date:  1994-12       Impact factor: 4.929

10.  Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation.

Authors:  J P Byrne; G R Armstrong; S E Attwood
Journal:  Am J Gastroenterol       Date:  1998-10       Impact factor: 10.864

View more
  1 in total

1.  Abnormal expression of biomarkers in incompletely ablated Barrett's esophagus.

Authors:  Katerina Dvorak; Lois Ramsey; Claire M Payne; Richard Sampliner; Ronnie Fass; Harris Bernstein; Anil Prasad; Harinder Garewal
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.